LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.22 | 771.67 | 1693 | 1741 | 0.9722 | 0.9526 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.22 | 771.67 | 1833 | 1741 | 1.0526 | 1.0893 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.44 | 771.67 | 1716 | 1910 | 0.8980 | 0.8421 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.44 | 771.67 | 1839 | 1910 | 0.9624 | 0.9422 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.66 | 771.67 | 1753 | 2141 | 0.8186 | 0.7458 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.66 | 771.67 | 1924 | 2141 | 0.8984 | 0.8597 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.89 | 771.67 | 1811 | 2397 | 0.7553 | 0.6847 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.89 | 771.67 | 1939 | 2397 | 0.8087 | 0.7565 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.11 | 771.67 | 1814 | 2675 | 0.6781 | 0.6105 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.11 | 771.67 | 2015 | 2675 | 0.7532 | 0.7077 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.33 | 771.67 | 1880 | 2939 | 0.6396 | 0.5865 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 29.33 | 771.67 | 2107 | 2939 | 0.7168 | 0.6830 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.55 | 771.67 | 1903 | 3196 | 0.5953 | 0.5530 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 31.55 | 771.67 | 2151 | 3196 | 0.6729 | 0.6486 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.78 | 771.67 | 2048 | 3499 | 0.5852 | 0.5644 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 33.78 | 771.67 | 2276 | 3499 | 0.6504 | 0.6420 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.00 | 771.67 | 2126 | 3884 | 0.5473 | 0.5444 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.00 | 771.67 | 2421 | 3884 | 0.6232 | 0.6329 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.22 | 771.67 | 2244 | 4299 | 0.5219 | 0.5384 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.22 | 771.67 | 2512 | 4299 | 0.5842 | 0.6101 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.44 | 771.67 | 2407 | 4738 | 0.5080 | 0.5441 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.44 | 771.67 | 2690 | 4738 | 0.5677 | 0.6111 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 42.67 | 771.67 | 2596 | 5155 | 0.5035 | 0.5570 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 42.67 | 771.67 | 2914 | 5155 | 0.5652 | 0.6240 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.89 | 771.67 | 2704 | 5541 | 0.4880 | 0.5541 | MN20160304_L01 | I11 |